A Phase 2a, Open-label, Dose-ranging Study of the Safety and Effectiveness of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Phase of Trial: Phase II
Latest Information Update: 31 May 2017
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Frozen shoulder
- Focus Therapeutic Use
- Sponsors Auxilium Pharmaceuticals; Endo Pharmaceuticals
- 26 Mar 2013 Top-line results published in a BioSpecifics Technologies Corporation media release.
- 25 Mar 2013 Primary endpoint 'Range-of-motion (active forward flexion in the affected shoulder)' has been met.
- 25 Mar 2013 Top-line results published in an Auxilium Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History